| Trial ID: | L2049 |
| Source ID: | NCT00673894
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Effects of Glutamine on GLP-1 and Insulin Secretion in Man
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00673894/results
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Postprandial Glucose Area Under the Curve (AUC), The area under the curve (AUC) of the postprandial glucose following a meal challenge, 0 to 180 minutes | Secondary: Fructosamine, The blood concentration of the glycemic control marker fructosamine, 4 weeks
|
| Sponsor/Collaborators: |
Sponsor: Garvan Institute of Medical Research
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
22
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-04
|
| Completion Date: |
2014-11
|
| Results First Posted: |
2019-05-13
|
| Last Update Posted: |
2019-05-13
|
| Locations: |
Clinical Research Facility, Sydney, New South Wales, 2010, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT00673894
|
